Daniel Fernandes to Humans
This is a "connection" page, showing publications Daniel Fernandes has written about Humans.
Connection Strength
0.161
-
Novel mechanisms in the regulation of G protein-coupled receptor trafficking to the plasma membrane. J Biol Chem. 2010 Oct 29; 285(44):33816-25.
Score: 0.014
-
Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells. Mol Pharmacol. 2009 Nov; 76(5):984-91.
Score: 0.013
-
Overexpression of nucleolin in engrafted acute myelogenous leukemia cells. Am J Hematol. 2009 Aug; 84(8):535-8.
Score: 0.013
-
The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells. Cancer Res. 2008 Apr 01; 68(7):2358-65.
Score: 0.012
-
Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. Blood. 2007 Apr 01; 109(7):3069-75.
Score: 0.011
-
Merbarone induces activation of caspase-activated DNase and excision of chromosomal DNA loops from the nuclear matrix. Mol Pharmacol. 2006 Apr; 69(4):1477-85.
Score: 0.010
-
Retinoid-induced apoptosis in HL-60 cells is associated with nucleolin down-regulation and destabilization of Bcl-2 mRNA. Mol Pharmacol. 2005 Jan; 67(1):319-26.
Score: 0.009
-
Drug-induced destabilization of bcl-2 mRNA: a new approach for inducing apoptosis in tumor cells. Curr Opin Investig Drugs. 2004 Jun; 5(6):616-22.
Score: 0.009
-
Quantitation of gene-specific DNA damage by competitive PCR. Anal Biochem. 2002 Jul 15; 306(2):212-21.
Score: 0.008
-
Imbalanced DNA synthesis induced by cytosine arabinoside and fludarabine in human leukemia cells. Biochem Pharmacol. 2001 Jul 01; 62(1):101-10.
Score: 0.007
-
Topoisomerase II cleavable complex formation within DNA loop domains. Biochem Pharmacol. 2000 Jul 01; 60(1):101-9.
Score: 0.007
-
Arrest of replication fork progression at sites of topoisomerase II-mediated DNA cleavage in human leukemia CEM cells incubated with VM-26. Biochemistry. 1997 May 13; 36(19):5739-48.
Score: 0.006
-
Formation of topoisomerase II alpha complexes with nascent DNA is related to VM-26-induced cytotoxicity. Biochemistry. 1996 Dec 17; 35(50):16354-60.
Score: 0.005
-
The nuclear matrix as a target for cancer therapy. Ann Oncol. 1996 Sep; 7(7):659-66.
Score: 0.005
-
GTP depletion induced by IMP dehydrogenase inhibitors blocks RNA-primed DNA synthesis. Mol Pharmacol. 1995 May; 47(5):948-55.
Score: 0.005
-
DNA topoisomerase II isozymes involved in anticancer drug action and resistance. Adv Enzyme Regul. 1995; 35:265-81.
Score: 0.005
-
The nuclear matrix as a site of anticancer drug action. Int Rev Cytol. 1995; 162A:539-76.
Score: 0.005
-
Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A. Blood. 2011 Jun 02; 117(22):5941-52.
Score: 0.004
-
Mechanism of regulation of bcl-2 mRNA by nucleolin and A+U-rich element-binding factor 1 (AUF1). J Biol Chem. 2010 Aug 27; 285(35):27182-27191.
Score: 0.003
-
Regulation of Bcl-2 expression by HuR in HL60 leukemia cells and A431 carcinoma cells. Mol Cancer Res. 2009 Aug; 7(8):1354-66.
Score: 0.003
-
Identification of nucleolin as an AU-rich element binding protein involved in bcl-2 mRNA stabilization. J Biol Chem. 2004 Mar 19; 279(12):10855-63.
Score: 0.002
-
Taxol- and okadaic acid-induced destabilization of bcl-2 mRNA is associated with decreased binding of proteins to a bcl-2 instability element. Biochem Pharmacol. 2003 Oct 01; 66(7):1151-62.
Score: 0.002
-
PALA enhancement of bromodeoxyuridine incorporation into DNA increases radiation cytotoxicity to human ovarian adenocarcinoma cells. Int J Radiat Oncol Biol Phys. 1996 Mar 15; 34(5):1073-9.
Score: 0.001